Cynthia J. Davenport, Ph.D., owner and President, is an expert pharmaceutical consultant and toxicologist with over 18 years of experience with global, multi-disciplinary drug development teams, toxicology, drug safety, non-clinical study directing, regulatory strategy, medical writing, and project management. She has a strong background in supervisory and project management roles within multiple therapeutic areas (human and veterinary), with a specialty in neurotoxicology. Dr. Davenport has managed drug candidates from early through advanced phases of development in a diverse, matrixed environment at legacy Pfizer (almost 17 years). She has a solid track record of problem solving and problem prevention. Dr. Davenport is a strong team player, both as an individual contributor and in a leadership role. Her leadership style is goal driven and results oriented.
Toxicology • Neurotoxicology • Non-Clinical/Preclinical Drug Safety • IND Enabling Studies • Non-Clinical Drug Development Strategies • Drug Development Team Involvement/Leadership • Project Management • CRO Selection • Study Design, Placement, and Monitoring • Data Analyses • Report Writing and/or Review • Integrated Summary Document Preparation • Clinical Investigator Brochures • Toxicology Portions of Regulatory Submissions • Impurity/Metabolite Qualification • Scientific Literature Reviews • Expert Report/ White Paper Preparation • Manuscript Preparation • Due-diligence Reviews • Academic Liaison • Peer Review